NF1 and cancer: Beyond NF1, data from medulloblastoma cohorts also demonstrate a markedly increased risk: the observed-to-expected ratio of secondary malignant neoplasms was 4.49 (95% CI: 3.53-5.62), with a particularly elevated ratio in the CNS (40.62; 95% CI: 25.46-61.51).